Lucas AT - Search Results

1

Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents.

Lucas AT, Madden AJ, Zamboni WC. Lucas AT, et al. Expert Opin Drug Metab Toxicol. 2015;11(9):1419-33. doi: 10.1517/17425255.2015.1057496. Epub 2015 Jul 20. Expert Opin Drug Metab Toxicol. 2015. PMID: 26173794 Review.

2

A sensitive high performance liquid chromatography assay for the quantification of doxorubicin associated with DNA in tumor and tissues.

Lucas AT, O'Neal SK, Santos CM, White TF, Zamboni WC. Lucas AT, et al. J Pharm Biomed Anal. 2016 Feb 5;119:122-9. doi: 10.1016/j.jpba.2015.11.035. Epub 2015 Nov 28. J Pharm Biomed Anal. 2016. PMID: 26678179 Free PMC article.

3

Challenges in preclinical to clinical translation for anticancer carrier-mediated agents.

Lucas AT, Madden AJ, Zamboni WC. Lucas AT, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Sep;8(5):642-53. doi: 10.1002/wnan.1394. Epub 2016 Feb 5. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016. PMID: 26846457 Review.

4

Gulp1 is associated with the pharmacokinetics of PEGylated liposomal doxorubicin (PLD) in inbred mouse strains.

Song G, Suzuki OT, Santos CM, Lucas AT, Wiltshire T, Zamboni WC. Song G, et al. Among authors: lucas at. Nanomedicine. 2016 Oct;12(7):2007-2017. doi: 10.1016/j.nano.2016.05.019. Epub 2016 Jun 9. Nanomedicine. 2016. PMID: 27288666

5

Profiling the relationship between tumor-associated macrophages and pharmacokinetics of liposomal agents in preclinical murine models.

Lucas AT, White TF, Deal AM, Herity LB, Song G, Santos CM, Zamboni WC. Lucas AT, et al. Nanomedicine. 2017 Feb;13(2):471-482. doi: 10.1016/j.nano.2016.09.015. Epub 2016 Oct 5. Nanomedicine. 2017. PMID: 27720926

6

Pharmacokinetic and screening studies of the interaction between mononuclear phagocyte system and nanoparticle formulations and colloid forming drugs.

Lucas AT, Herity LB, Kornblum ZA, Madden AJ, Gabizon A, Kabanov AV, Ajamie RT, Bender DM, Kulanthaivel P, Sanchez-Felix MV, Havel HA, Zamboni WC. Lucas AT, et al. Int J Pharm. 2017 Jun 30;526(1-2):443-454. doi: 10.1016/j.ijpharm.2017.04.079. Epub 2017 May 2. Int J Pharm. 2017. PMID: 28473237

7

Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents.

Lucas AT, Price LS, Schorzman A, Zamboni WC. Lucas AT, et al. Nanomedicine (Lond). 2017 Aug;12(16):2021-2042. doi: 10.2217/nnm-2017-0101. Epub 2017 Jul 26. Nanomedicine (Lond). 2017. PMID: 28745129 Free PMC article. Review.

8

Methods and Study Designs for Characterizing the Pharmacokinetics and Pharmacodynamics of Carrier-Mediated Agents.

Schorzman AN, Lucas AT, Kagel JR, Zamboni WC. Schorzman AN, et al. Among authors: lucas at. Methods Mol Biol. 2018;1831:201-228. doi: 10.1007/978-1-4939-8661-3_15. Methods Mol Biol. 2018. PMID: 30051434

9

Animal models for analysis of immunological responses to nanomaterials: Challenges and considerations.

Zamboni WC, Szebeni J, Kozlov SV, Lucas AT, Piscitelli JA, Dobrovolskaia MA. Zamboni WC, et al. Among authors: lucas at. Adv Drug Deliv Rev. 2018 Nov-Dec;136-137:82-96. doi: 10.1016/j.addr.2018.09.012. Epub 2018 Sep 29. Adv Drug Deliv Rev. 2018. PMID: 30273617 Review.

10

Mononuclear phagocyte system function and nanoparticle pharmacology in obese and normal weight ovarian and endometrial cancer patients.

Starling BR, Kumar P, Lucas AT, Barrow D, Farnan L, Hendrix L, Giovinazzo H, Song G, Gehrig P, Bensen JT, Zamboni WC. Starling BR, et al. Among authors: lucas at. Cancer Chemother Pharmacol. 2019 Jan;83(1):61-70. doi: 10.1007/s00280-018-3702-9. Epub 2018 Oct 16. Cancer Chemother Pharmacol. 2019. PMID: 30327876 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page